Halozyme announces departure of COO Cortney Caudill

HALOZYME THERAPEUTICS, INC.

Cortney Caudill departed as SVP, Chief Operating Officer on June 30, 2026.
No replacement has been named; company thanked Caudill for her contributions.
Departure is part of an update to senior management structure.

item 5.02

HALOZYME THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001159036-26-000088

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.